82 related articles for article (PubMed ID: 1002362)
1. Comparison of the effects of atenolol and practolol on exercise tachycardia in normal subjects.
Myers MG; George CF
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):266-70. PubMed ID: 1002362
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of intravenous administration of atenolol and practolol on resting and exercise-evoked increase in heart rate and cardiac work load in normal human subjects.
Sharma PL
Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):27-30. PubMed ID: 838525
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the activity of beta-adrenoceptor antagonists in man.
Taylor SH; Thadani U; Davidson C; singleton W; Myint S
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
[TBL] [Abstract][Full Text] [Related]
4. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
[TBL] [Abstract][Full Text] [Related]
5. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
Sharma PL
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of atenolol.
Barrett AM
Postgrad Med J; 1977; 53 Suppl 3():58-64. PubMed ID: 928267
[No Abstract] [Full Text] [Related]
7. Effect of atenolol on ventilatory and cardiac function in asthma.
Vilsvik JS; Schaanning J
Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
[TBL] [Abstract][Full Text] [Related]
8. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
[TBL] [Abstract][Full Text] [Related]
9. [Use of a new beta-blocking agent, ICI-66082].
Grau Real F; Rodrigo Baeza F
Rev Esp Anestesiol Reanim; 1975 May; 22(3):243-8. PubMed ID: 1162152
[No Abstract] [Full Text] [Related]
10. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
11. [Tokolysis and dose-dependent effects of beta-blocking with atenolol in the rabbit].
Steib L; Czekelius P; Behr J
Z Geburtshilfe Perinatol; 1982; 186(3):145-9. PubMed ID: 6889791
[TBL] [Abstract][Full Text] [Related]
12. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
Williams FM; Singh BN; Ambler PK; Dorrington R
Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
[TBL] [Abstract][Full Text] [Related]
13. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
Svendsen TL; Hartling O; Trap-Jensen J
Eur J Clin Pharmacol; 1979 May; 15(4):223-8. PubMed ID: 38968
[No Abstract] [Full Text] [Related]
14. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C
Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between digoxin and atenolol in chronic atrial fibrillation].
Lanas F; Salvatici R; Castillo G; Montecinos A; Stockins B; Molina E
Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
[TBL] [Abstract][Full Text] [Related]
17. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
Clementi WA; Garvey TQ; Clifton GD; McCoy RA; Brandt S; Schwartz S
Chirality; 1994; 6(3):169-74. PubMed ID: 8024947
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
[TBL] [Abstract][Full Text] [Related]
19. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
